Name
Kose Hambaravi Osaühing
Registry code
10282703
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.10.1997 (27)
Financial year
01.01-31.12
Capital
9 587.00 €
Activity
86231 - Provision of dental treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maie Matšenas 27.09.1967 (57) | 100% - 9 587.00 EUR | Board member | Direct ownership | Founder |
| 2019 09.09.2020 | 2020 04.07.2021 | 2021 08.12.2022 | 2022 06.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 1 212 826 € | 1 592 396 € | 1 756 185 € | 1 999 646 € |
| Net profit (loss) for the period | 48 548 € | 37 261 € | 39 641 € | -64 463 € |
| Profit Margin | 4% | 2% | 2% | -3% |
| Current Assets | 183 236 € | 215 402 € | 220 275 € | 143 158 € |
| Fixed Assets | 260 045 € | 275 615 € | 276 522 € | 269 936 € |
| Total Assets | 443 281 € | 491 017 € | 496 797 € | 413 094 € |
| Current Liabilities | 191 066 € | 218 404 € | 247 789 € | 254 149 € |
| Non Current Liabilities | 16 863 € | 0 € | 0 € | 0 € |
| Total Liabilities | 207 929 € | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 235 352 € | 272 613 € | 249 008 € | 158 945 € |
| Employees | 26 | 33 | 33 | 34 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 145 688.94 € | 155 615.13 € | 39 |
| 2023 Q4 | - | 140 760.88 € | 150 564.62 € | 41 |
| 2023 Q3 | - | 144 688.72 € | 155 024.09 € | 37 |
| 2023 Q2 | - | 124 965.23 € | 133 908.05 € | 35 |
| 2023 Q1 | - | 138 000.02 € | 146 538.98 € | 38 |
| 2022 Q4 | - | 148 411.26 € | 157 970.62 € | 37 |
| 2022 Q3 | - | 104 376.06 € | 115 135.27 € | 31 |
| 2022 Q2 | - | 113 902.75 € | 122 644.6 € | 35 |
| 2022 Q1 | - | 114 842.57 € | 123 647.3 € | 33 |
| 2021 Q4 | - | 134 637.53 € | 137 558.99 € | 32 |
| 2021 Q3 | - | 97 424.68 € | 107 063.62 € | 31 |
| 2021 Q2 | - | 109 471.47 € | 118 385.83 € | 33 |
| 2021 Q1 | - | 105 876.16 € | 114 601.14 € | 33 |
| 2020 Q4 | - | 112 983.72 € | 121 160.94 € | 33 |
| 2020 Q3 | - | 98 736.57 € | 106 913.85 € | 31 |
| 2020 Q2 | - | 33 918.64 € | 36 137.48 € | 31 |
| 2020 Q1 | - | 57 619.37 € | 63 484.17 € | 31 |
